サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1588568

カンナビゲロール（CBG）グミの世界市場：2024年～2031年

Global Cannabigerol (CBG) Gummies Market - 2024-2031

出版日
ページ情報
英文 184 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
カンナビゲロール（CBG）グミの世界市場：2024年～2031年
出版日: 2024年11月08日
発行: DataM Intelligence
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界のカンナビゲロール（CBG）グミ市場は、2023年に24億7,000万米ドルに達し、2024年から2031年の予測期間中に43.5％のCAGRで成長し、2031年までに444億米ドルに達すると予測されています。

カンナビゲロール（CBG）グミは、大麻植物に含まれるカンナビノイドの一種で、精神作用のないカンナビゲロールを配合した噛みごたえのある菓子です。しばしば「すべてのカンナビノイドの母」と呼ばれるCBGは、CBD（カンナビジオール）やTHC（テトラヒドロカンナビノール）などの他のカンナビノイドが派生する基礎化合物としての役割を果たします。

カンナビゲロール（CBG）グミは、特定量のCBGエキスを含み、様々な香料や甘味料が配合されており、消費者にとって魅力的な選択肢となっています。ソフトキャンディやハードキャンディなど、さまざまな種類があり、フルスペクトラム、ブロードスペクトラム、分離型のカンナビノイドを使用して製造することができます。

市場力学：

促進要因

大麻の合法化と製品イノベーション

世界のカンナビゲロール（CBG）グミ市場の需要は、複数の要因によって牽引されています。主な要因の1つは、大麻の合法化と製品イノベーションです。医療目的であれ娯楽目的であれ、大麻が合法化されたことで、カンナビゲロール（CBG）のようなカンナビノイドを含む製品の市場アクセスや消費者層が大幅に拡大しました。より多くの州や国が大麻を合法化する動きに伴い、消費者はCBGグミを含むより多様な大麻由来製品にアクセスできるようになった。このような入手しやすさの向上は、より多くの人々がこれらの製品を探求することを促し、市場の成長に貢献しています。

CBGグミ市場では、ウェルネス志向の製品に対する消費者の需要の高まりに対応するため、各社が継続的に技術革新を行っています。人々は、人工的な添加物ではなく、植物由来の天然成分を利用した製品に関心を寄せています。こうした需要に応えるため、各社はオーガニックのサトウキビ糖、フルーツペクチン、スピルリナやウコンのような天然由来の香料や着色料を使ってCBGグミを製造しています。このようなクリーンな成分へのシフトは、CBGの潜在的な効果を体験するためのより自然なアプローチを求める健康志向の消費者にとって特に魅力的です。

さらに、提携や協力などの主要企業の戦略は、このカンナビゲロール（CBG）グミ市場の成長を促進すると思われます。例えば、2022年6月、Cronos Group Inc.は、8種類の培養カンナビノイドを生産する共同研究において、3つ目の生産性のマイルストーンに到達したと発表しました。イチョウの生物設計プラットフォームを活用し、クロノス社はTHCの食欲刺激作用を緩和すると考えられているカンナビノイド、テトラヒドロカンナビバリン（THCV）の生産性目標を達成することに成功しました。さらなる希少カンナビノイドへのアクセスは、クロノスのイノベーション・パイプラインを強化し、商業化戦略をサポートします。

阻害要因

高い生産コストや規制上の課題などが、市場の妨げになると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 大麻の合法化と製品の革新
    • 抑制要因
      • 高い生産コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 カテゴリー別

  • カンナビジオール（CBD）食用
  • カンナビゲロール（CBG）
  • カンナビノール（CBN）

第7章 フレーバー別

  • ラズベリージュース
  • ストロベリージュース
  • チェリージュース
  • ストロベリーピューレ
  • ラズベリーパウダー
  • その他

第8章 形態別

  • ハードキャンディ
  • ソフトキャンディ

第9章 用途別

  • 抗炎症
  • 神経保護
  • 不安とストレス管理
  • 睡眠補助
  • 気分調節
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Curaleaf Holding Inc.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • The Cronos Group
  • Charlotte's Web, Inc.
  • Rare Cannabinoid Company.
  • Lazarus Naturals Inc.
  • Hemptown Naturals
  • Green Roads LLC
  • Medterra
  • ENDOCA
  • Extract Labs

第13章 付録

目次
Product Code: PH8705

Overview

The global cannabigerol (CBG) gummies market reached US$ 2.47 billion in 2023 and is expected to reach US$ 44.4 billion by 2031 growing with a CAGR of 43.5% during the forecast period 2024-2031.

Cannabigerol (CBG) gummies are chewy confections that are infused with cannabigerol, a cannabinoid found in the cannabis plant that does not produce psychoactive effects. Often called the "mother of all cannabinoids," CBG serves as a foundational compound from which other cannabinoids, such as CBD (cannabidiol) and THC (tetrahydrocannabinol), are derived.

Cannabigerol (CBG) gummies are formulated to contain a specific amount of CBG extract, along with various flavorings and sweeteners, making them an appealing choice for consumers. They come in different varieties, including soft and hard candies, and can be produced using full-spectrum, broad-spectrum, or isolated forms of cannabinoids.

Market Dynamics: Drivers

Legalization of cannabis and product innovations

The demand for the global cannabigerol (CBG) gummies market is driven by multiple factors. One of the primary factors is the legalization of cannabis and product innovations. The legalization of cannabis, whether for medical or recreational purposes, has significantly expanded the market access and consumer base for products containing cannabinoids like Cannabigerol (CBG). As more states and countries move to legalize cannabis, consumers have greater access to a wider variety of cannabis-derived products, including CBG gummies. This increased accessibility encourages more people to explore these products, contributing to market growth.

Companies are continuously innovating in the CBG gummies market to meet the growing consumer demand for wellness-oriented products. People are more interested in products that utilize natural, plant-based ingredients instead of artificial additives. In response to this demand, companies are formulating CBG gummies with organic cane sugar, fruit pectin, and natural flavors and colors derived from sources like spirulina and turmeric. This shift towards clean ingredients is particularly appealing to health-conscious consumers who seek a more natural approach to experiencing the potential benefits of CBG.

Moreover, key player strategies such as partnerships and collaborations would propel this cannabigerol (CBG) gummies market growth. For instance, in June 2022, Cronos Group Inc. announced that they had reached the third productivity milestone in their collaboration to produce eight cultured cannabinoids. Utilizing Ginkgo's organism design platform, Cronos has successfully met the productivity target for tetrahydrocannabivarin (THCV), a cannabinoid believed to mitigate the appetite-stimulating effects of THC. This access to additional rare cannabinoids will enhance Cronos' innovation pipeline and support its commercialization strategy.

Restraints

Factors such as high production costs, and regulatory challenges, are expected to hamper the market.

Segment Analysis

The global cannabigerol (CBG) gummies market is segmented based on category, flavor, form, application, and region.

The cannabigerol (CBG) segment accounted for approximately 66.4% of the global cannabigerol (CBG) gummies market share

The cannabigerol (CBG) segment is expected to hold the largest market share over the forecast period. Cannabigerol (CBG) gummies are typically made with natural ingredients, including fruit flavors, to enhance their taste and appeal to consumers. Each gummy contains a pre-measured dose of CBG, providing a consistent and convenient method for incorporating this cannabinoid into daily routines.

While CBG shows potential in promoting mental focus, supporting brain health, and fostering relaxation, further research is essential to fully understand its effects and therapeutic possibilities. Consumers should consult healthcare professionals before starting any new supplements or products.

Moreover, key players in the industry introduced innovative product launches that would propel this cannabigerol (CBG) gummies market growth. For instance, in April 2024, Rare Cannabinoid Company launched special 420 deals on its THC Mood Gummies and CBD oils, celebrating the cannabis culture and offering consumers affordable access to high-quality products. This promotion is particularly notable as it aligns with the 420 holiday, recognized in the cannabis community as a day to celebrate and advocate for cannabis use.

The THC Mood Gummies feature a blend of Delta-9-THC, CBG (cannabigerol), and CBD (cannabidiol), creating a unique edible designed to enhance mood while supporting physical wellness. Each gummy aims to provide a balanced experience, combining the euphoric effects of THC with the calming properties of CBG and CBD. This formulation is intended to offer users a natural way to manage stress and discomfort while promoting overall well-being.

Also, in October 2021, Cronos Group Inc. announced the launch of its SPINACH FEELZ Chill Bliss 2:1 THC|CBG gummy, marking a significant innovation in the cannabis edible market in Canada. This product is notable as it is the first cannabis gummy in Canada to incorporate both THC and cultured cannabigerol (CBG) derived from fermentation processes, rather than directly from the cannabis plant.

The Chill Bliss gummy is designed to provide a balanced experience, delivering 10 mg of THC and 5 mg of CBG per package, which contains two gummies. Available in a Pineapple Starfruit flavor, this product aims to offer consumers a sweet and enjoyable way to experience the effects of these cannabinoids.

Geographical Analysis

North America accounted for approximately 44.2% of the global cannabigerol (CBG) gummies market share

North America region is expected to hold the largest market share over the forecast period owing to the ongoing legalization of cannabis for medical and recreational purposes in numerous states across the U.S. has greatly broadened the market for CBG products. This legal environment enables consumers to access a diverse array of cannabinoid products, including CBG gummies, without the stigma that often accompanies illegal substances.

In this region, as awareness of cannabinoids increases, a growing number of consumers are recognizing the potential benefits of cannabigerol (CBG) gummies. In contrast to more well-known cannabinoids like CBD and THC, CBG is in more demand for its distinctive properties, including anti-inflammatory effects and neuroprotective advantages. This increased awareness is fueling demand for products infused with CBG.

Moreover, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, innovative product launches, and rising customization & personalization of CBG gummies, would propel this cannabigerol (CBG) gummies market growth. For instance, in November 2023, in U.S. Rare Cannabinoid Company, a prominent innovator in the hemp industry, unveiled its innovative product THC + CBG Relief Gummies. This revolutionary edible combines the power of Delta-9-THC, CBG, and CBD, offering consumers a natural solution to support their physical well-being. Each gummy contains a potent blend of 2.5mg Delta-9-THC, 30mg CBG, and 10mg CBD in a delightful green apple flavor, with 30 gummies per bottle. This convenient and enjoyable formulation aims to provide the potential benefits of these cannabinoids for physical wellness.

Similarly, in December 2022, KANHA, a renowned cannabis brand, launched its CBG "Harmony" gummies, which are positioned as a high-end product within the cannabinoid market. Each package contains a total of 300 mg of lab-tested cannabinoids, featuring twice the CBG content compared to competing offerings. This elevated concentration of CBG is intended to provide enhanced therapeutic benefits for consumers interested in this lesser-known cannabinoid.

The Harmony gummies are specifically formulated to promote both mental and physical wellness, utilizing cannabis-derived terpenes that contribute to a more comprehensive effect. Made with real fruit flavors and all-natural ingredients, these gummies reflect KANHA's dedication to quality and consumer safety. Additionally, the incorporation of NANO technology in the formulation improves absorption, allowing effects to be felt as soon as 15 minutes after consumption.

Market Segmentation

By Category

  • Cannabidiol (CBD) Edible
  • Cannabigerol (CBG)
  • Cannabinol (CBN)

By Flavor

  • Raspberry Juice
  • Strawberry Juice
  • Cherry Juice
  • Strawberry Puree
  • Raspberry Powder
  • Others

By Form

  • Hard Candy
  • Soft Candy

By Application

  • Anti-Inflammatory
  • Neuroprotection
  • Anxiety and Stress Management
  • Sleep Aid
  • Mood Regulation
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • The rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the cannabigerol (CBG) gummies market include Curaleaf Holding Inc., The Cronos Group, Charlotte's Web, Inc., Rare Cannabinoid Company., Lazarus Naturals Inc., Hemptown Naturals, Green Roads LLC, Medterra, ENDOCA, and Extract Labs among others.

Key Developments

  • In August 2024, nuEra, a prominent cannabis dispensary chain in Illinois, launched its innovative Alchemy Ratio product line, which includes both gummies and vape cartridges. This new series is crafted to provide consumers with a more balanced and therapeutic cannabis experience, delivering targeted relief through a carefully calibrated blend of cannabinoids.

Why Purchase the Report?

  • To visualize the global cannabigerol (CBG) gummies market segmentation based on category, flavor, form, application, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the cannabigerol (CBG) gummies market with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global cannabigerol (CBG) gummies market report would provide approximately 70 tables, 67 figures, and 184 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Category
  • 3.2. Snippet by Flavor
  • 3.3. Snippet by Form
  • 3.4. Snippet by Application
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Legalization of Cannabis and Product Innovations
    • 4.1.2. Restraints
      • 4.1.2.1. High Production Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Category

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 6.1.2. Market Attractiveness Index, By Category
  • 6.2. Cannabidiol (CBD) Edible*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Cannabigerol (CBG)
  • 6.4. Cannabinol (CBN)

7. By Flavor

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 7.1.2. Market Attractiveness Index, By Flavor
  • 7.2. Raspberry Juice *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Strawberry Juice
  • 7.4. Cherry Juice
  • 7.5. Strawberry Puree
  • 7.6. Raspberry Powder
  • 7.7. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Hard Candy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Soft Candy

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Anti-Inflammatory*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Neuroprotection
  • 9.4. Anxiety and Stress Management
  • 9.5. Sleep Aid
  • 9.6. Mood Regulation
  • 9.7. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Curaleaf Holding Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. The Cronos Group
  • 12.3. Charlotte's Web, Inc.
  • 12.4. Rare Cannabinoid Company.
  • 12.5. Lazarus Naturals Inc.
  • 12.6. Hemptown Naturals
  • 12.7. Green Roads LLC
  • 12.8. Medterra
  • 12.9. ENDOCA
  • 12.10. Extract Labs

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us